Orsiro 2.25/30/140Recalls & reported problems
Biotronik AG · Class 3 · Implant
All models of Orsiro (49)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 07640130439207), received between Jul 15, 2019 and Oct 19, 2021 — classified as 7 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated4
- Failure to Advance3
- Material Deformation1
Patient problems
- No Consequences Or Impact To Patient6
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 19, 2021Device Dislodged or Dislocated; Device Dislodged or Dislocated
PHYSICIAN WAS TREATING A PATIENT AND WENT TO DEPLOY THIS 2.25/30 ORSIRO. DEVICE WAS PREPPED BUT THERE WAS NO STENT ON THE BALLOON. THEY HAD TO USE A SECOND STENT. THIS WAS ORIGINALLY REPORTED ON MDR-1028232-2021-05694, BUT THE SIZE, MODEL AND LOT NUMBER WERE INCORRECT. THAT REPORT WAS CLOSED AND THIS ONE OPENED IN ITS PLACE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12656254 ↗MalfunctionFeb 3, 2020Failure to Advance; Material Deformation; Failure to Advance; Material Deformation
AN ORSIRO DRUG-ELUTING STENT SYSTEM WAS CHOSEN FOR TREATMENT OF A LESION IN THE RCA. THE LESION COULD NOT BE CROSSED WITH THE DEVICE AND WAS REMOVED. AFTER WITHDRAWAL IT WAS DETECTED THAT THE STENT WAS DEFORMED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9661739 ↗MalfunctionNov 26, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
AN ORSIRO DRUG-ELUTING STENT SYSTEM WAS CHOSEN TO TREAT A LESION IN THE PROXIMAL CX. DURING THE PROCEDURE THE ORSIRO STENT DISLODGED FROM THE BALLOON AND WAS ADAPTED TO THE VESSEL WALL.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9379993 ↗MalfunctionNov 21, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
AN ORSIRO DRUG-ELUTING STENT SYSTEM WAS SELECTED FOR TREATMENT. AFTER REMOVING THE STENT PROTECTOR AND FLUSHING THE DEVICE IT WAS DECIDED TO PRE-DILATE THE LESION A SECOND TIME, SO THE STENT WAS ON TABLE UNDER A TOWEL. WHEN INSERTING THE STENT SYSTEM IT WAS NOTICED THAT THE STENT WAS NOT ON THE BALLOON.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9356816 ↗MalfunctionAug 6, 2019Failure to Advance; Failure to Advance
THE ORSIRO DRUG-ELUTING STENT SYSTEM WAS SELECTED FOR USE. DURING LESION CROSSING THE ORSIRO COULD NOT CROSS THE SEVERELY CALCIFIED AND TORTUOUS TARGET LESION IN THE LAD.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8866653 ↗MalfunctionJul 24, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
AN ORSIRO DRUG-ELUTING STENT SYSTEM WAS CHOSEN TO TREAT A SEVERELY CALCIFIED LESION IN A TORTUOUS RCA. DURING PROCEDURE THE STENT DISLODGED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8824083 ↗MalfunctionJul 15, 2019Failure to Advance; Failure to Advance
AN ORSIRO DRUG-ELUTING STENT SYSTEM WAS CHOSEN TO TREAT A CALCIFIED LESION (99 PERCENT STENOSIS DEGREE) IN A CX. THE DEVICE COULD NOT CROSS THE PRE-DILATED LESION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8791650 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page